These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 10067677)
21. Comparative study of structurally related peptidoglycan monomer and muramyl dipeptide on humoral IgG immune response to ovalbumin in mouse. Habjanec L; Halassy B; Tomasić J Int Immunopharmacol; 2010 Jul; 10(7):751-9. PubMed ID: 20403461 [TBL] [Abstract][Full Text] [Related]
22. Immunomodulatory activity of novel adjuvant formulations based on Montanide ISA oil-based adjuvants and peptidoglycan monomer. Habjanec L; Halassy B; Tomasić J Int Immunopharmacol; 2008 May; 8(5):717-24. PubMed ID: 18387514 [TBL] [Abstract][Full Text] [Related]
23. Humoral immune responses in mice using gamma inulin preparations as adjuvants for hepatitis B vaccines. Leslie DE; Nicholson S; Dimitrakakis M; Johnston N; Gust ID Immunol Cell Biol; 1990 Apr; 68 ( Pt 2)():107-12. PubMed ID: 1696560 [TBL] [Abstract][Full Text] [Related]
24. Adjuvant Potential of Poly-α-l-Glutamine from the Cell Wall of Mycobacterium tuberculosis. Mani R; Gupta M; Malik A; Tandon R; Prasad R; Bhatnagar R; Banerjee N Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30104212 [TBL] [Abstract][Full Text] [Related]
26. Synthetic adjuvants for vaccine formulations: evaluation of new phytol derivatives in induction and persistence of specific immune response. Aachoui Y; Schulte ML; Fitch RW; Ghosh SK Cell Immunol; 2011; 271(2):308-18. PubMed ID: 21855057 [TBL] [Abstract][Full Text] [Related]
27. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses. Schiött A; Larsson K; Manniche S; Kalliomäki S; Heydenreich AV; Dalsgaard K; Kirkby N Int J Pharm; 2011 Jul; 414(1-2):312-20. PubMed ID: 21601626 [TBL] [Abstract][Full Text] [Related]
28. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems. Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124 [TBL] [Abstract][Full Text] [Related]
29. Naloxone/alum mixture a potent adjuvant for HIV-1 vaccine: induction of cellular and poly-isotypic humoral immune responses. Velashjerdi Farahani S; Reza Aghasadeghi M; Memarnejadian A; Faezi S; Shahosseini Z; Mahdavi M Pathog Glob Health; 2016 Mar; 110(2):39-47. PubMed ID: 26403975 [TBL] [Abstract][Full Text] [Related]
30. Increased adjuvant efficacy in stimulation of antibody responses after macrophage elimination in vivo. Leenaars PP; Savelkoul HF; Hendriksen CF; Van Rooijen N; Claassen E Immunology; 1997 Mar; 90(3):337-43. PubMed ID: 9155638 [TBL] [Abstract][Full Text] [Related]
31. Immunogenicity of Streptococcus pneumoniae type 14 capsular polysaccharide: influence of carriers and adjuvants on isotype distribution. van de Wijgert JH; Verheul AF; Snippe H; Check IJ; Hunter RL Infect Immun; 1991 Aug; 59(8):2750-7. PubMed ID: 1855991 [TBL] [Abstract][Full Text] [Related]
32. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii. Song P; He S; Zhou A; Lv G; Guo J; Zhou J; Han Y; Zhou H; Hao Z; Cong H BMC Infect Dis; 2017 Jan; 17(1):19. PubMed ID: 28056837 [TBL] [Abstract][Full Text] [Related]
33. Vaccination against the nematode Trichinella spiralis in high- and low-responder mice. Effects of different adjuvants upon protective immunity and immune responsiveness. Robinson K; Bellaby T; Wakelin D Immunology; 1994 Jun; 82(2):261-7. PubMed ID: 7927498 [TBL] [Abstract][Full Text] [Related]
34. Studies on the adjuvant activity of non-ionic surfactant vesicles: adjuvant-driven IgG2a production independent of MHC control. Brewer JM; Alexander J Vaccine; 1994 May; 12(7):613-9. PubMed ID: 8085378 [TBL] [Abstract][Full Text] [Related]
35. Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines. ten Hagen TL; Sulzer AJ; Kidd MR; Lal AA; Hunter RL J Immunol; 1993 Dec; 151(12):7077-85. PubMed ID: 8258712 [TBL] [Abstract][Full Text] [Related]
36. Regulation of isotype immunoglobulin production by adjuvants in vivo. Karagouni EE; Hadjipetrou-Kourounakis L Scand J Immunol; 1990 Jun; 31(6):745-54. PubMed ID: 1694039 [TBL] [Abstract][Full Text] [Related]
37. A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine. Sugai T; Mori M; Nakazawa M; Ichino M; Naruto T; Kobayashi N; Kobayashi Y; Minami M; Yokota S Vaccine; 2005 Nov; 23(46-47):5450-6. PubMed ID: 16006019 [TBL] [Abstract][Full Text] [Related]
38. [Mouse macrophage-derived chemokine as an adjuvant enhances the protective effect of P6 protein vaccine of nontypeable Haemophilus influenzae]. Han X; Wang C; Qiao H; Zhang Y; Chang Y; Zhang Y Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Sep; 30(9):913-6. PubMed ID: 25200152 [TBL] [Abstract][Full Text] [Related]
39. Immune responses and side effects of five different oil-based adjuvants in mice. Leenaars M; Koedam MA; Hendriksen CF; Claassen E Vet Immunol Immunopathol; 1998 Feb; 61(2-4):291-304. PubMed ID: 9613442 [TBL] [Abstract][Full Text] [Related]
40. CoVaccine HT™ adjuvant is superior to Freund's adjuvants in eliciting antibodies against the endogenous alarmin HMGB1. Lakhan N; Stevens NE; Diener KR; Hayball JD J Immunol Methods; 2016 Dec; 439():37-43. PubMed ID: 27693642 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]